Antimuscarinic nasal spray (rhinorrhoea)
Pregnancy: Use with caution — limited data. Systemic absorption minimal via nasal route.
Ipratropium Bromide 0.03% Nasal Spray (Rinatec)
Brand names: Rinatec
Adult dose
Dose: 2 sprays (42 micrograms) into each nostril 2–3 times daily
Route: Intranasal
Frequency: 2–3 times daily
Max: 8 sprays (168 micrograms) per day
Rhinorrhoea (watery nasal discharge): 2 sprays per nostril 2–3 times daily. Reduces watery secretion from nasal mucosa (antisecretory — not decongestant). Indicated for: perennial non-allergic rhinitis (vasomotor rhinitis), rhinorrhoea of allergic rhinitis not controlled by antihistamines/steroids, gustatory rhinitis (rhinorrhoea triggered by eating). Onset within 15 minutes.
Paediatric dose
Route: Intranasal
Frequency: 2–3 times daily
Max: 168 micrograms/day
6–11 years: 2 sprays per nostril 3 times daily (0.03%). ≥12 years: adult dose. Not licensed under 6 years.
Dose adjustments
Renal
No specific dose adjustment required.
Hepatic
No specific dose adjustment required.
Clinical pearls
- Specifically targets watery rhinorrhoea — does not treat nasal obstruction or sneezing (unlike antihistamines/steroids)
- Excellent for gustatory rhinitis (watery runny nose triggered by hot/spicy food) — 2 sprays 30 min before eating
- Vasomotor rhinitis (non-allergic, non-infectious rhinorrhoea): ipratropium nasal is most effective pharmacological option
- Onset of action within 15 minutes — reassure patient
- Elderly patients: caution regarding urinary retention and precipitation of glaucoma
Contraindications
- Hypersensitivity to ipratropium or atropine
- Narrow-angle glaucoma (systemic absorption — rare but possible with nasal administration)
- Bladder outflow obstruction (prostatic hypertrophy)
Side effects
- Nasal dryness and irritation
- Epistaxis
- Headache
- Dry mouth (anticholinergic)
- Urinary retention (rare — systemic absorption)
- Worsening of narrow-angle glaucoma (rare)
Interactions
- Other antimuscarinics — additive anticholinergic side effects
- Inhaled ipratropium (tiotropium) — additive anticholinergic burden if used simultaneously
Monitoring
- Symptom response (rhinorrhoea control)
- Urinary symptoms in at-risk males
Reference: BNFc; BNF; BSACI Non-Allergic Rhinitis Guidelines; Rinatec SPC. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020